# Mdxhealth to Release First Quarter 2026 Financial Results on May 13
Canonical URL: https://biopharmsignal.com/news/MDXH/mdxhealth-to-release-first-quarter-2026-financial-results-on-may-13-70772180
Ticker: MDXH
Company: MDxHealth
Source: MDxHealth
Published: 2026-04-30 20:00 EST
## Summary

Mdxhealth SA (NASDAQ: MDXH), a leading precision diagnostics company, today announced it will release its financial results for the first quarter ended...

## Article Body
Mdxhealth to Release First Quarter 2026 Financial Results on May 13

Company to Host Conference Call with Live Q&A, May 13, 2026, at 4:30pm ET / 22:30 CET

IRVINE, California – April 30, 2026 ( GlobeNewswire ) – Mdxhealth SA (NASDAQ: MDXH), a leading precision diagnostics company, today announced it will release its financial results for the first quarter ended March 31, 2026, after market close on Wednesday, May 13, 2026.

| Title: | Mdxhealth Presents First Quarter 2026 Financial Results and Corporate Update Conference Call and Webcast |
| --- | --- |
| Date: | May 13, 2026 |
| Time: | 4:30pm ET/ 22:30 CET |
| Conference Call D ial-in Details: | United States : 1-800-245-3047 Belgium : 0800 72 519 United Kingdom : 0808 101 1183 |
| Conference ID: | MDX1Q26 |
| Webcast: | https://viavid.webcasts.com/starthere.jsp?ei=1758088&tp_key=21da6e9d38 |

The webcast should be accessed 15 minutes prior to the conference call start time. A replay of the webcast will be available following the conclusion of the live call and will be accessible on the Company’s website.

About Mdxhealth

Mdxhealth is a leading precision diagnostics company that provides actionable molecular information to personalize patient diagnosis and treatment. The Company’s tests, based on proprietary genomic, epigenomic, exosomal and other molecular technologies, assist physicians with the diagnosis and prognosis of prostate cancer and other urologic diseases. For more information, visit mdxhealth.com and follow us on social media at: twitter.com/mdxhealth, facebook.com/mdxhealth and linkedin.com/company/mdxhealth.

For more information:

info@mdxhealth.com

LifeSci Advisors (IR & PR) John Fraunces, Managing Director Tel: +1 917 355 2395 jfraunces@lifesciadvisors.com

MDXH 1Q26 Earnings Save the Date (May13)
## Recent Company News
- 2026-07-24 20:59 EST — [Mdxhealth Announces Receipt of Nasdaq Notification Regarding  Minimum Market Value of Listed Securities Deficiency](https://biopharmsignal.com/news/MDXH/mdxhealth-announces-receipt-of-nasdaq-notification-regarding-minimum-market-valu-cf439d90) — Source: MDxHealth
- 2026-07-02 20:00 EST — [Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency](https://biopharmsignal.com/news/MDXH/mdxhealth-announces-receipt-of-nasdaq-notification-regarding-minimum-bid-price-d-bdf178d6) — Source: MDxHealth
- 2026-06-29 12:00 EST — [Mdxhealth Announces Peer-Reviewed Publication of Oxford GPS-ProMPT Study in European Urology Oncology, Establishing Scientific Foundation for the Landmark GPS-ProtecT Randomized Controlled Trial](https://biopharmsignal.com/news/MDXH/mdxhealth-announces-peer-reviewed-publication-of-oxford-gps-prompt-study-in-euro-d931d4ac) — Source: MDxHealth
- 2026-05-13 20:00 EST — [Mdxhealth Reports Q1-2026 Results](https://biopharmsignal.com/news/MDXH/mdxhealth-reports-q1-2026-results-52a85fa2) — Source: MDxHealth
- 2026-04-30 20:00 EST — [Mdxhealth to Release First Quarter 2026 Financial Results on May 13](https://biopharmsignal.com/news/MDXH/mdxhealth-to-release-first-quarter-2026-financial-results-on-may-13-70772180) — Source: MDxHealth
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)